nach oben

International Journal of Clinical Oncology

Erschienen in:

04.09.2015 | Original Article

Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy

verfasst von: Takaaki Higashi, Hiromitsu Hayashi, Katsunobu Taki, Keita Sakamoto, Hideyuki Kuroki, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Toru Beppu, Hideo Baba

Erschienen in: International Journal of Clinical Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Major hepatectomy is associated with significant morbidity and mortality rates, particularly in patients aged more than 70 years. This study assessed whether physical indicators, such as sarcopenia and visceral fat amount, could predict morbidity and mortality after major hepatectomy.

Methods

The study enrolled 144 patients who underwent curative major hepatectomy. Skeletal muscle and visceral fat amount at the third lumbar vertebra (L3) in the inferior direction were quantified using enhanced computed tomography scans. The patients were divided into two subgroups, with and without sarcopenia, based on median skeletal muscle mass in men and women (43.2 cm²/m² in men; 35.3 cm²/m² in women).

Results

The study included 108 men and 36 women, with median skeletal muscle tissue of 43.2 and 35.3 cm²/m², respectively. The mortality rate was significantly higher in patients with than without sarcopenia [seven cases (9.7 %), one case (1.4 %), respectively; P = 0.021], whereas liver-related morbidity and mortality rates were similar. In patients aged >70 years, the morbidity, liver dysfunction-related morbidity, and mortality rates were significantly higher in patients with than without sarcopenia (P < 0.05 each). In contrast, surgical outcomes were similar in patients with high and low visceral fat amounts.

Conclusions

Sarcopenia was a risk factor for postoperative complications after major hepatectomy, particularly in elderly patients.

Nur mit Berechtigung zugänglich

Aldrighetti L, Arru M, Caterini R et al (2003) Impact of advanced age on the outcome of liver resection. World J Surg 27:1149–1154CrossRefPubMed

Cho SW, Steel J, Tsung A et al (2011) Safety of liver resection in the elderly: how important is age? Ann Surg Oncol 18:1088–1095CrossRefPubMed

Liu L, Chen H, Wang M et al (2014) Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis. PLoS One 9:e91124CrossRefPubMedPubMedCentral

Fong Y, Brennan MF, Cohen AM et al (1997) Liver resection in the elderly. Br J Surg 84:1386–1390CrossRefPubMed

Palavecino M, Kishi Y, Chun YS et al (2010) Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery (St. Louis) 147:40–48CrossRef

Reddy SK, Barbas AS, Turley RS et al (2011) A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxf) 13:494–502CrossRef

Reddy SK, Barbas AS, Turley RS et al (2011) Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg 212:787–795CrossRefPubMed

Yang T, Zhang J, Lu JH et al (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082CrossRefPubMed

Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (St. Louis) 149:713–724CrossRef

10.

Andreou A, Vauthey JN, Cherqui D et al (2013) Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg 17:66–77 (discussion p. 77) CrossRefPubMed

11.

Laurent C, Sa Cunha A, Couderc P et al (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131–1136CrossRefPubMed

12.

Vigano L, Ferrero A, Tesoriere RL et al (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458–2464CrossRefPubMed

13.

Mastoraki A, Tsakali A, Papanikolaou IS et al (2014) Outcome following major hepatic resection in the elderly patients. Clin Res Hepatol Gastroenterol 38:462–466CrossRefPubMed

14.

Ezaki T, Yukaya H, Ogawa Y (1987) Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br J Surg 74:471–473CrossRefPubMed

15.

Tan BH, Birdsell LA, Martin L et al (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15:6973–6979CrossRefPubMed

16.

van Vledder MG, Levolger S, Ayez N et al (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99:550–557CrossRefPubMed

17.

Sabel MS, Lee J, Cai S et al (2011) Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 18:3579–3585CrossRefPubMed

18.

Montano-Loza AJ, Meza-Junco J, Prado CM et al (2012) Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 10:166–173 (173–e161) CrossRefPubMed

19.

Englesbe MJ, Patel SP, He K et al (2010) Sarcopenia and mortality after liver transplantation. J Am Coll Surg 211:271–278CrossRefPubMedPubMedCentral

20.

Harimoto N, Shirabe K, Yamashita YI et al (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523–1530CrossRefPubMed

21.

Peng PD, van Vledder MG, Tsai S et al (2011) Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxf) 13:439–446CrossRef

22.

Makary MA, Segev DL, Pronovost PJ et al (2010) Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 210:901–908CrossRefPubMed

23.

Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefPubMed

24.

Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ (2009) Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 208:53–61CrossRefPubMed

25.

Itoh S, Ikeda Y, Kawanaka H et al (2012) The effect of overweight status on the short-term and 20-y outcomes after hepatic resection in patients with hepatocellular carcinoma. J Surg Res 178:640–645CrossRefPubMed

26.

Yoshizumi T, Nakamura T, Yamane M et al (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211:283–286CrossRefPubMed

27.

Mitsiopoulos N, Baumgartner RN, Heymsfield SB et al (1998) Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85(1):115–122PubMed

28.

Kashihara H, Lee JS, Kawakubo K et al (2009) Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J 73:1881–1886CrossRefPubMed

29.

Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed

30.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral

31.

Paugam-Burtz C, Janny S, Delefosse D et al (2009) Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249:124–128CrossRefPubMed

32.

Lieffers JR, Bathe OF, Fassbender K et al (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107:931–936CrossRefPubMedPubMedCentral

33.

Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457–465CrossRefPubMed

34.

Aldrighetti L, Arru M, Catena M et al (2006) Liver resections in over-75-year-old patients: surgical hazard or current practice? J Surg Oncol 93:186–193CrossRefPubMed

35.

Adam R, Frilling A, Elias D et al (2010) Liver resection of colorectal metastases in elderly patients. Br J Surg 97:366–376CrossRefPubMed

36.

Nishikawa H, Kimura T, Kita R et al (2013) Treatment for hepatocellular carcinoma in elderly patients: a literature review. J Cancer 4:635–643CrossRefPubMedPubMedCentral

37.

Koperna T, Kisser M, Schulz F (1998) Hepatic resection in the elderly. World J Surg 22:406–412CrossRefPubMed

38.

Sugisawa N, Tokunaga M, Tanizawa Y et al (2012) Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer 15:206–212CrossRefPubMed

39.

Cecchini S, Cavazzini E, Marchesi F et al (2011) Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg 35:415–423CrossRefPubMed

40.

Gaujoux S, Torres J, Olson S et al (2012) Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol 19:2908–2916CrossRefPubMed

41.

Saunders JK, Rosman AS, Neihaus D et al (2012) Safety of hepatic resections in obese veterans. Arch Surg 147:331–337CrossRefPubMed

Titel: Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy
verfasst von: Takaaki Higashi
Hiromitsu Hayashi
Katsunobu Taki
Keita Sakamoto
Hideyuki Kuroki
Hidetoshi Nitta
Daisuke Hashimoto
Akira Chikamoto
Toru Beppu
Hideo Baba
Publikationsdatum: 04.09.2015
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 2/2016
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-015-0898-0

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy